The protection of fourth dose mRNA vaccination against SARS-CoV-2 is relevant to current global policy decisions regarding ongoing booster roll-out.

Discover the experiences and opinions of three female scientists at the University of Birmingham, who are working on finding out more about how insulin-making beta cells function and how new ones can grow in the lab.

Human infection challenge permits in-depth, early, and pre-symptomatic characterization of the immune response, enabling the identification of factors that are important for viral clearance.

Latest information about circulation, impact and what is needed to prevent infections, severe disease, post-COVID-19 condition and deaths.

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections (LRTI) in children.

Repeated doses of mRNA vaccines for COVID-19 result in increased proportions of anti-spike antibodies of the IgG4 subclass.

Bivalent mRNA COVID-19 vaccines were recommended in the US for children and adolescents aged 12 years or older on September 1, 2022, and for children aged 5 to 11 years on October 12, 2022.

Nearly 20 million people aged 60 years and above received COVID-19 vaccines during the autumn/winter campaign in the EU/EEA, according to a new report from the European Centre for Disease Prevention and Control (ECDC).

Sign the Diabetes Community Pledge to support the 32 million people living with diabetes in the European Union and their families. Take action by creating a strong EU diabetes policy framework supportive of national diabetes action plans.

Since the COVID-19 pandemic began, wastewater-based surveillance has been used to track circulation levels of SARS-CoV-2.

With the world gradually recovering from the COVID-19 pandemic, it is important to think forward when it comes to prevention of infectious disease outbreaks originating from the animal world.